相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators
Sumanta Garai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Allosteric modulators restore orthosteric agonist binding to mutated CB1 receptors
Rachel Dopart et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Impact of GPCR Structures on Drug Discovery
Miles Congreve et al.
CELL (2020)
Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity
Mariama Jaiteh et al.
PLoS Computational Biology (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor
Haiyi Chen et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from Turnera diffusa (Damiana)
Narayan D. Chaurasiya et al.
MOLECULES (2019)
Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation
Oscar Diaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers
Yuemin Bian et al.
MOLECULAR PHARMACEUTICS (2019)
Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure-Activity Relationship Studies
Dow P. Hurst et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Scott A. Hollingsworth et al.
NATURE COMMUNICATIONS (2019)
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors
Shivani Sachdev et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
Francesca Gado et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities
Szymon Hryhorowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE CHEMICAL BIOLOGY (2019)
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Dai Lu et al.
ACTA PHARMACOLOGICA SINICA (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor
Annalaura Sabatucci et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
The future of type 1 cannabinoid receptor allosteric ligands
Mariam Alaverdashvili et al.
DRUG METABOLISM REVIEWS (2018)
Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment
Jason S. E. Loo et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Gitanjali Srivastava et al.
CURRENT OBESITY REPORTS (2018)
Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists
Amey Dhopeshwarkar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen et al.
MEDICINAL RESEARCH REVIEWS (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure
Xiangyu Liu et al.
NATURE (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Modulation of CBI cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana et al.
NEUROPHARMACOLOGY (2017)
Zombie Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Axel J. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Obesity: Current and potential pharmacotherapeutics and targets
Vidya Narayanaswami et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice (vol 8, 707, 2017)
Wei Chen et al.
FRONTIERS IN PHARMACOLOGY (2017)
Advances and challenges in the search for D2 and D3 dopamine receptor selective compounds
Amy E. Moritz et al.
CELLULAR SIGNALLING (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1
Sergio Oddi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
Pushkar M. Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains
Jacques Fantini et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Aliou B. Gueye et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Yi Zheng et al.
NATURE (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Intracellular allosteric antagonism of the CCR9 receptor
Christine Oswald et al.
NATURE (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
Richard S. Priestley et al.
FASEB JOURNAL (2015)
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments
Mariano Stornaiuolo et al.
SCIENTIFIC REPORTS (2015)
XSEDE: Accelerating Scientific Discovery
John Towns et al.
COMPUTING IN SCIENCE & ENGINEERING (2014)
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING
Derek M. Shore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallee et al.
SCIENCE (2014)
The Membrane Proximal Region of the Cannabinoid Receptor CB1 N-Terminus Can Allosterically Modulate Ligand Affinity
Jonathan F. Fay et al.
BIOCHEMISTRY (2013)
Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)
Kwang H. Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains
Jacques Fantini et al.
FRONTIERS IN PHYSIOLOGY (2013)
JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities
Robert J. Chorvat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A Key Agonist-induced Conformational Change in the Cannabinoid Receptor CB1 Is Blocked by the Allosteric Ligand Org 27569
Jonathan F. Fay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors
Mark Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Current Assessment of Docking into GPCR Crystal Structures and Homology Models: Successes, Challenges, and Guidelines
Thijs Beuming et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor
Sergio Oddi et al.
JOURNAL OF NEUROCHEMISTRY (2011)
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
N. L. Cluny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
Joong-Youn Shim
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
Tony Jourdan et al.
DIABETES (2010)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
Liyun Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
End of the line for cannabinoid receptor 1 as an anti-obesity target?
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2008)
A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor
Michael A. Hanson et al.
STRUCTURE (2008)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cholesterol and the interaction of proteins with membrane domains
Richard M. Epand
PROGRESS IN LIPID RESEARCH (2006)
OPM: Orientations of proteins in membranes database
MA Lomize et al.
BIOINFORMATICS (2006)
Use of an induced fit receptor structure in virtual screening
W Sherman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
CB1 cannabinoid receptor ligands
GA Thakur et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Development of a 3D model for the human cannabinoid CB1 receptor
OMH Salo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
CR Trillou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction
JY Shim et al.
BIOPOLYMERS (2003)
分享论文
